Henry Schein, Inc. (0L3C.L)
USD 65.7
(-0.98%)
USD 65.7
(-0.98%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.93 Billion USD | 47.0% |
| 2022 | 1.31 Billion USD | 21.86% |
| 2021 | 1.07 Billion USD | 43.02% |
| 2020 | 754.5 Million USD | -5.59% |
| 2019 | 799.17 Million USD | -20.39% |
| 2018 | 1 Billion USD | 10.59% |
| 2017 | 907.75 Million USD | 26.88% |
| 2016 | 715.45 Million USD | 54.28% |
| 2015 | 463.75 Million USD | -14.56% |
| 2014 | 542.77 Million USD | 20.55% |
| 2013 | 450.23 Million USD | -7.76% |
| 2012 | 488.12 Million USD | 34.27% |
| 2011 | 363.52 Million USD | -8.04% |
| 2010 | 395.3 Million USD | 62.43% |
| 2009 | 243.37 Million USD | -8.73% |
| 2008 | 266.64 Million USD | -37.0% |
| 2007 | 423.27 Million USD | -7.14% |
| 2006 | 455.8 Million USD | -6.89% |
| 2005 | 489.52 Million USD | -6.88% |
| 2004 | 525.68 Million USD | 112.74% |
| 2003 | 247.1 Million USD | 1.87% |
| 2002 | 242.56 Million USD | 0.16% |
| 2001 | 242.16 Million USD | -9.04% |
| 2000 | 266.22 Million USD | -16.33% |
| 1999 | 318.2 Million USD | 76.39% |
| 1998 | 180.4 Million USD | 93.56% |
| 1997 | 93.2 Million USD | 278.86% |
| 1996 | 24.6 Million USD | -19.08% |
| 1995 | 30.4 Million USD | -40.97% |
| 1994 | 51.5 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.89 Billion USD | -5.92% |
| 2024 Q1 | 2.01 Billion USD | 3.98% |
| 2023 Q1 | 1.29 Billion USD | -1.52% |
| 2023 Q3 | 2.12 Billion USD | 50.25% |
| 2023 Q2 | 1.41 Billion USD | 9.42% |
| 2023 FY | 1.93 Billion USD | 47.0% |
| 2023 Q4 | 1.93 Billion USD | -9.21% |
| 2022 Q2 | 769 Million USD | -26.76% |
| 2022 Q1 | 1.05 Billion USD | -2.7% |
| 2022 FY | 1.31 Billion USD | 21.86% |
| 2022 Q4 | 1.31 Billion USD | 40.79% |
| 2022 Q3 | 934 Million USD | 21.46% |
| 2021 Q3 | 975.69 Million USD | 2.73% |
| 2021 FY | 1.07 Billion USD | 43.02% |
| 2021 Q1 | 755.08 Million USD | 0.08% |
| 2021 Q2 | 949.71 Million USD | 25.78% |
| 2021 Q4 | 1.07 Billion USD | 10.6% |
| 2020 Q1 | 1.02 Billion USD | 28.73% |
| 2020 Q2 | 679.14 Million USD | -33.99% |
| 2020 Q3 | 715.96 Million USD | 5.42% |
| 2020 Q4 | 754.5 Million USD | 5.38% |
| 2020 FY | 754.5 Million USD | -5.59% |
| 2019 Q1 | 1.16 Billion USD | 15.63% |
| 2019 FY | 799.17 Million USD | -20.39% |
| 2019 Q2 | 1.15 Billion USD | -0.81% |
| 2019 Q3 | 1.05 Billion USD | -8.39% |
| 2019 Q4 | 799.17 Million USD | -24.23% |
| 2018 Q3 | 1 Billion USD | 1.52% |
| 2018 Q2 | 985.38 Million USD | -1.51% |
| 2018 Q1 | 1 Billion USD | 10.22% |
| 2018 FY | 1 Billion USD | 10.59% |
| 2018 Q4 | 1 Billion USD | 0.36% |
| 2017 Q1 | 708.42 Million USD | -0.98% |
| 2017 FY | 907.75 Million USD | 26.88% |
| 2017 Q4 | 907.75 Million USD | 0.02% |
| 2017 Q3 | 907.59 Million USD | 12.38% |
| 2017 Q2 | 807.62 Million USD | 14.0% |
| 2016 Q4 | 715.45 Million USD | -0.36% |
| 2016 Q2 | 700.05 Million USD | 5.07% |
| 2016 Q1 | 666.28 Million USD | 43.67% |
| 2016 FY | 715.45 Million USD | 54.28% |
| 2016 Q3 | 718.02 Million USD | 2.57% |
| 2015 Q4 | 463.75 Million USD | -22.33% |
| 2015 FY | 463.75 Million USD | -14.56% |
| 2015 Q3 | 597.1 Million USD | 1.46% |
| 2015 Q2 | 588.52 Million USD | -9.97% |
| 2015 Q1 | 653.71 Million USD | 20.44% |
| 2014 Q2 | 665.9 Million USD | 22.93% |
| 2014 Q3 | 630.8 Million USD | -5.27% |
| 2014 Q4 | 542.77 Million USD | -13.96% |
| 2014 Q1 | 541.68 Million USD | 20.31% |
| 2014 FY | 542.77 Million USD | 20.55% |
| 2013 FY | 450.23 Million USD | -7.76% |
| 2013 Q4 | 450.23 Million USD | 44.56% |
| 2013 Q3 | 311.45 Million USD | -30.28% |
| 2013 Q2 | 446.7 Million USD | -25.62% |
| 2013 Q1 | 600.59 Million USD | 23.04% |
| 2012 Q1 | 453.05 Million USD | 24.63% |
| 2012 Q3 | 436.42 Million USD | 0.46% |
| 2012 Q2 | 434.41 Million USD | -4.11% |
| 2012 FY | 488.12 Million USD | 34.27% |
| 2012 Q4 | 488.12 Million USD | 11.85% |
| 2011 Q2 | 372.92 Million USD | -8.48% |
| 2011 FY | 363.52 Million USD | -8.04% |
| 2011 Q4 | 363.52 Million USD | -2.24% |
| 2011 Q3 | 371.86 Million USD | -0.28% |
| 2011 Q1 | 407.46 Million USD | 3.07% |
| 2010 Q2 | 523.42 Million USD | 0.1% |
| 2010 FY | 395.3 Million USD | 62.43% |
| 2010 Q1 | 522.88 Million USD | 114.85% |
| 2010 Q4 | 395.3 Million USD | 3.08% |
| 2010 Q3 | 383.49 Million USD | -26.73% |
| 2009 FY | 243.37 Million USD | -8.73% |
| 2009 Q2 | 261.22 Million USD | 1.91% |
| 2009 Q3 | 242.51 Million USD | -7.17% |
| 2009 Q4 | 243.37 Million USD | 0.36% |
| 2009 Q1 | 256.33 Million USD | -3.87% |
| 2008 FY | 266.64 Million USD | -37.0% |
| 2008 Q4 | 266.64 Million USD | -0.87% |
| 2008 Q1 | 428.54 Million USD | 1.24% |
| 2008 Q2 | 424.47 Million USD | -0.95% |
| 2008 Q3 | 268.99 Million USD | -36.63% |
| 2007 Q3 | 432.27 Million USD | -3.99% |
| 2007 FY | 423.27 Million USD | -7.14% |
| 2007 Q1 | 457.31 Million USD | 0.33% |
| 2007 Q2 | 450.26 Million USD | -1.54% |
| 2007 Q4 | 423.27 Million USD | -2.08% |
| 2006 Q4 | 455.8 Million USD | -0.15% |
| 2006 FY | 455.8 Million USD | -6.89% |
| 2006 Q3 | 456.48 Million USD | -6.08% |
| 2006 Q2 | 486.01 Million USD | -0.45% |
| 2006 Q1 | 488.21 Million USD | -0.27% |
| 2005 FY | 489.52 Million USD | -6.88% |
| 2005 Q2 | 518.95 Million USD | 0.36% |
| 2005 Q3 | 513.59 Million USD | -1.03% |
| 2005 Q4 | 489.52 Million USD | -4.69% |
| 2005 Q1 | 517.09 Million USD | -1.63% |
| 2004 Q2 | 420.87 Million USD | 53.98% |
| 2004 Q4 | 525.68 Million USD | 0.56% |
| 2004 Q3 | 522.76 Million USD | 24.21% |
| 2004 Q1 | 273.32 Million USD | 10.61% |
| 2004 FY | 525.68 Million USD | 112.74% |
| 2003 FY | 247.1 Million USD | 1.87% |
| 2003 Q4 | 247.1 Million USD | 0.7% |
| 2003 Q3 | 245.38 Million USD | -0.72% |
| 2003 Q1 | 242.86 Million USD | 0.13% |
| 2003 Q2 | 247.17 Million USD | 1.78% |
| 2002 Q2 | 242.99 Million USD | 0.42% |
| 2002 Q3 | 242.14 Million USD | -0.35% |
| 2002 Q4 | 242.56 Million USD | 0.17% |
| 2002 FY | 242.56 Million USD | 0.16% |
| 2002 Q1 | 241.96 Million USD | -0.08% |
| 2001 Q1 | 253.87 Million USD | -4.64% |
| 2001 Q4 | 242.16 Million USD | -3.38% |
| 2001 FY | 242.16 Million USD | -9.04% |
| 2001 Q3 | 250.65 Million USD | -0.06% |
| 2001 Q2 | 250.79 Million USD | -1.21% |
| 2000 Q3 | 272.17 Million USD | -2.84% |
| 2000 Q4 | 266.22 Million USD | -2.19% |
| 2000 Q1 | 306.26 Million USD | -3.75% |
| 2000 Q2 | 280.12 Million USD | -8.53% |
| 2000 FY | 266.22 Million USD | -16.33% |
| 1999 FY | 318.2 Million USD | 76.39% |
| 1999 Q4 | 318.2 Million USD | 8.42% |
| 1999 Q3 | 293.5 Million USD | -7.76% |
| 1999 Q2 | 318.2 Million USD | -1.64% |
| 1999 Q1 | 323.5 Million USD | 79.32% |
| 1998 Q1 | 123.4 Million USD | 32.4% |
| 1998 Q3 | 182 Million USD | 46.54% |
| 1998 Q4 | 180.4 Million USD | -0.88% |
| 1998 FY | 180.4 Million USD | 93.56% |
| 1998 Q2 | 124.2 Million USD | 0.65% |
| 1997 Q2 | 41.6 Million USD | 75.53% |
| 1997 FY | 93.2 Million USD | 278.86% |
| 1997 Q4 | 93.2 Million USD | 10.95% |
| 1997 Q1 | 23.7 Million USD | -3.66% |
| 1997 Q3 | 84 Million USD | 101.92% |
| 1996 Q4 | 24.6 Million USD | -0.81% |
| 1996 Q1 | 51.7 Million USD | 70.07% |
| 1996 Q2 | 25.3 Million USD | -51.06% |
| 1996 Q3 | 24.8 Million USD | -1.98% |
| 1996 FY | 24.6 Million USD | -19.08% |
| 1995 Q4 | 30.4 Million USD | 0.0% |
| 1995 FY | 30.4 Million USD | -40.97% |
| 1994 FY | 51.5 Million USD | 0.0% |
| 1994 Q4 | 51.5 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -94238.702% |
| Accuray Incorporated | 164.4 Million USD | -1075.791% |
| Align Technology, Inc. | 96.96 Million USD | -1893.441% |
| Elevance Health Inc. | 23.24 Billion USD | 91.685% |
| AxoGen, Inc. | 46.6 Million USD | -4047.802% |
| Boston Scientific Corporation | 8.56 Billion USD | 77.434% |
| CVS Health Corporation | 74.67 Billion USD | 97.411% |
| Cardinal Health, Inc. | 4.58 Billion USD | 57.822% |
| Centene Corporation | 17.69 Billion USD | 89.078% |
| DaVita Inc. | 8.05 Billion USD | 75.991% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 94.723% |
| Hologic, Inc. | 2.49 Billion USD | 22.59% |
| Humana Inc. | 10.21 Billion USD | 81.073% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -210.331% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | 52.327% |
| Masimo Corporation | 871.7 Million USD | -121.751% |
| McKesson Corporation | 5.45 Billion USD | 64.539% |
| Patterson Companies, Inc. | 328.91 Million USD | -487.697% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | 56.168% |
| ResMed Inc. | 697.31 Million USD | -177.207% |
| Teladoc Health, Inc. | 1.58 Billion USD | -22.224% |
| Universal Health Services, Inc. | 4.71 Billion USD | 59.013% |
| Veeva Systems Inc. | 46.44 Million USD | -4062.27% |
| Baxter International Inc. | 11.06 Billion USD | 82.529% |
| Becton, Dickinson and Company | 14.73 Billion USD | 86.884% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 2454.446% |
| Danaher Corporation | 17.66 Billion USD | 89.055% |
| Stryker Corporation | 10.9 Billion USD | 82.268% |
| Medtronic plc | 23.87 Billion USD | 91.904% |